|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Collaboration revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| Other income, net: | |||||
| Interest income | |||||
| Other income | |||||
| Total other income, net | |||||
| (Loss) income before income taxes | |||||
| Income tax provision | |||||
| Net (loss) income | |||||
| Other comprehensive income (loss) | |||||
| Net unrealized gain (loss) on available-for-sale-securities | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Net (loss) income per share, basic (in dollars per share) | |||||
| Net (loss) income per share, diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in shares) | |||||
| Weighted-average common shares outstanding, diluted (in shares) |
Loading...